We build trusting relationships by delivering consistent quality
We are as passionate about our people, as they are about their work
We deliver high productivity through collaboration, teamwork and support
MDSL International is a well-established, UK based company providing high quality clinical data management solutions and statistics to the European biotechnology and pharmaceutical industry. Based in Berkshire in the Thames Valley, MDSL International is uniquely placed within the industry to provide a fully project managed, flexible service from start to finish on a wide range of clinical trials.
We pride ourselves in always doing whatever is needed to ensure that success of our customers' projects. If you have ever felt that your data deserve the best treatment that can be provided then you need to take a little time to browse round our website.
We will prove to you that we can deliver the quality that your projects deserve. Guided by MDSL International's committed management team and inspired by their Core Values, our employees work their absolute best so that you don't need to worry about your clinical data.
MDSL International - Protecting your investment in clinical data.
For sponsors it is critical that solution providers employ effective methods and expertise in clinical data management. For us accuracy is not a static measure but an advancing and challenging standard.
For over 15 years MDSL International has led the way in innovative statistical solutions. We are the bio-statistical partner of choice for many of Europe's mid-sized pharmaceutical companies as well as the virtual development team for ambitious start-up companies.
Our range of consultancy products has been designed to support our clients' clinical needs at various levels from program development, through protocol design to regulatory submission.
Our role, as an advisory service to the financial sector of the life science investment industry, is to micro analyse the trial data, to give you the detail behind the product’s performance, to ensure sophisticated investors can make the best investment choices and minimise risk.